Anika Therapeutics Inc (ANIK) Stock Analysis

Anika Therapeutics Inc (ANIK) is a publicly traded company in the HEALTHCARE sector. It trades at $14.38, carries a market capitalization of $193.33M. This page summarizes the public market data, fundamentals, and frequently asked questions for ANIK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Anika Therapeutics Inc currently has a Bullish sentiment score of 0.28.

About Anika Therapeutics Inc

Anika Therapeutics Inc. is a leader in joint preservation and regenerative therapies, focusing on innovative orthopedic solutions that enhance patient mobility and reduce pain. Headquartered in Bedford, Massachusetts, the company has established a strong presence in key markets including the U.S. and Europe. Anika's portfolio primarily consists of hyaluronic acid-based therapeutics, specifically targeting osteoarthritis and joint disorders, which strategically positions the firm within the ex...

GNG Research Analysis

GNG Research scores Anika Therapeutics Inc (ANIK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ANIK.

Frequently Asked Questions

Does ANIK pay dividends?

Anika Therapeutics Inc (ANIK) does not currently pay a regular dividend.

What is ANIK's market cap?

Anika Therapeutics Inc (ANIK) has a market capitalization of $193.33M with a current stock price of $14.38.